Sino Biopharmaceutical (1177.HK) traded down -1.8 % during a 24 hours period ending at 10:15 PM Central Europe on Tuesday 27th. One Sino Biopharmaceutical stock can currently be bought for about HKD 4.76 on popular exchanges. Current supply of Sino Biopharmaceutical stocks is 17.8 bn. Sino Biopharmaceutical has a current market capitalization of HKD 87.4 bn and approximately HKD 297.4 mn worth of Sino Biopharmaceutical was traded on exchanges in the last 24 hours. Since last month end, Sino Biopharmaceutical has traded -10.65 % down. Simple moving average of last 200 days is at HKD 5.59. The highest price of past 52 weeks was recorded at HKD 7.48 on 11/14/2025. 52 weeks low was at HKD 4.19 on 06/29/2026.
Here is how related stocks have performed in the past 24 hours:
Shein Global (K9J.F) traded up 4.75 % and now trades at EUR 4.2. Current market capitalisation for Shein Global is EUR 11.9 bn.
Sino Land (0083.HK) traded up 0.94 % and now trades at HKD 10.58. Sino Land has a market capitalisation of HKD 103.5 bn. Current price/earnings ratio for Sino Land is 22.08.
Hkt And Hkt (6823.HK) traded down -0.58 % and now trades at HKD 11.89. Current market capitalisation for Hkt And Hkt is HKD 90.2 bn. Current price/earnings ratio for Hkt And Hkt is 16.84.
Wharf Real Estate Investment (1997.HK) traded up 2.44 % and now trades at HKD 31.04. Current market capitalisation for Wharf Real Estate Investment is HKD 94.3 bn.
Wh (0288.HK) traded down -0.63 % and now trades at HKD 6.29. Wh has a market capitalisation of HKD 81.1 bn. Current price/earnings ratio for Wh is 6.71.
About Sino Biopharmaceutical
Sino Biopharmaceutical Limited is a health care company operating in the pharmaceutical industry, specializing in the research, development, production, and sale of biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.